2026 Global: Intensive Care Unit (Icu) Non-Invasive Cardiac Output Monitors (Nicom) Market -Competitive Review (2032) report
Description
The 2026 Global: Intensive Care Unit (Icu) Non-Invasive Cardiac Output Monitors (Nicom) Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Ten major players dominate the ICU non-invasive cardiac output monitoring (NICOM) market: Cheetah Medical, BMEYE BV, Nihon Kohden Corporation, Mindray Medical International, Philips Electronics NV. Cheetah Medical, headquartered in Needham, Massachusetts, United States, provides the BioZ NICOM platform that uses bioreactance to estimate stroke volume and cardiac output without intravascular access. BMEYE BV, based in Amsterdam, The Netherlands, markets Nexfin, a finger-cuff NICOM solution delivering continuous cardiac output and arterial pressure estimates from a noninvasive cuff. Nihon Kohden Corporation, headquartered in Tokyo, Japan, offers noninvasive hemodynamic modules integrated with its broad ICU monitoring portfolio, including impedance- or bioreactance-based cardiac output estimation. Mindray Medical International, headquartered in Shenzhen, China, is a major global supplier of ICU monitors with NICOM-enabled options that integrate into its patient-monitoring ecosystem. Philips Electronics NV, headquartered in Amsterdam, Netherlands, also markets NICOM-enabled monitors within its IntelliVue family, enabling noninvasive hemodynamic assessment alongside standard vital signs globally.
Masimo Corporation, headquartered in Irvine, California, United States, contributes noninvasive hemodynamic sensing through advanced sensor technology and software, and its NICOM-related capabilities are integrated with its broader physiological monitoring portfolio. GE Healthcare, based in Chicago, United States, provides noninvasive hemodynamic options within its extensive patient-monitoring ecosystem, including features that estimate cardiac output without invasive lines in certain care settings. Edwards Lifesciences, headquartered in Irvine, California, United States, offers noninvasive cardiac output assessment features in perioperative and critical-care platforms, complementing its invasive options. Getinge AB, based in Getinge, Sweden, supplies ICU monitoring solutions and hemodynamic tools within its comprehensive critical-care portfolio. Finapres Medical Systems, headquartered in Amsterdam, The Netherlands, develops finger-cuff NICOM using its Finapres technology, widely used in research and clinical settings. These capabilities enable continuous hemodynamic assessment in operating rooms, intensive care units, and transport settings, often interfacing with hospital information systems. These firms collectively anchor the NICOM landscape across North America, Europe, with the United States and The Netherlands hosting multiple dedicated NICOM developers while Japan and China contribute manufacturing and deployment capabilities. The push toward noninvasive hemodynamic monitoring reflects clinical demand for rapid, repeat cardiac output measurements without risks and logistical challenges of invasive methods. Market growth is shaped by hospital-system integration, interoperability standards, and clinical validation across surgical, critical-care, perioperative settings. As NICOM technologies evolve, vendors are focusing on improving measurement accuracy during hemodynamic instability, expanding finger-cuff reliability, and enhancing software analytics such as trend analysis, data fusion, and decision-support tools. Regulatory and reimbursement pathways will influence adoption rates, but the leading players identified here are well positioned to sustain leadership through broad geographic reach, cross-platform collaboration, and continued investment in research and development. Ultimately, adoption will hinge on evidence, reimbursement, clinician training, and patient outcomes globally. This fusion will shape NICOM strategy across hospitals worldwide dramatically.
Ten major players dominate the ICU non-invasive cardiac output monitoring (NICOM) market: Cheetah Medical, BMEYE BV, Nihon Kohden Corporation, Mindray Medical International, Philips Electronics NV. Cheetah Medical, headquartered in Needham, Massachusetts, United States, provides the BioZ NICOM platform that uses bioreactance to estimate stroke volume and cardiac output without intravascular access. BMEYE BV, based in Amsterdam, The Netherlands, markets Nexfin, a finger-cuff NICOM solution delivering continuous cardiac output and arterial pressure estimates from a noninvasive cuff. Nihon Kohden Corporation, headquartered in Tokyo, Japan, offers noninvasive hemodynamic modules integrated with its broad ICU monitoring portfolio, including impedance- or bioreactance-based cardiac output estimation. Mindray Medical International, headquartered in Shenzhen, China, is a major global supplier of ICU monitors with NICOM-enabled options that integrate into its patient-monitoring ecosystem. Philips Electronics NV, headquartered in Amsterdam, Netherlands, also markets NICOM-enabled monitors within its IntelliVue family, enabling noninvasive hemodynamic assessment alongside standard vital signs globally.
Masimo Corporation, headquartered in Irvine, California, United States, contributes noninvasive hemodynamic sensing through advanced sensor technology and software, and its NICOM-related capabilities are integrated with its broader physiological monitoring portfolio. GE Healthcare, based in Chicago, United States, provides noninvasive hemodynamic options within its extensive patient-monitoring ecosystem, including features that estimate cardiac output without invasive lines in certain care settings. Edwards Lifesciences, headquartered in Irvine, California, United States, offers noninvasive cardiac output assessment features in perioperative and critical-care platforms, complementing its invasive options. Getinge AB, based in Getinge, Sweden, supplies ICU monitoring solutions and hemodynamic tools within its comprehensive critical-care portfolio. Finapres Medical Systems, headquartered in Amsterdam, The Netherlands, develops finger-cuff NICOM using its Finapres technology, widely used in research and clinical settings. These capabilities enable continuous hemodynamic assessment in operating rooms, intensive care units, and transport settings, often interfacing with hospital information systems. These firms collectively anchor the NICOM landscape across North America, Europe, with the United States and The Netherlands hosting multiple dedicated NICOM developers while Japan and China contribute manufacturing and deployment capabilities. The push toward noninvasive hemodynamic monitoring reflects clinical demand for rapid, repeat cardiac output measurements without risks and logistical challenges of invasive methods. Market growth is shaped by hospital-system integration, interoperability standards, and clinical validation across surgical, critical-care, perioperative settings. As NICOM technologies evolve, vendors are focusing on improving measurement accuracy during hemodynamic instability, expanding finger-cuff reliability, and enhancing software analytics such as trend analysis, data fusion, and decision-support tools. Regulatory and reimbursement pathways will influence adoption rates, but the leading players identified here are well positioned to sustain leadership through broad geographic reach, cross-platform collaboration, and continued investment in research and development. Ultimately, adoption will hinge on evidence, reimbursement, clinician training, and patient outcomes globally. This fusion will shape NICOM strategy across hospitals worldwide dramatically.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
